Emerging Growth Focused Coverage

Innovative Sector Reports

Why Company Sponsored Research?

Twitter Feed

  • Diamond Equity Research

    RT @IPOtweet: Bumper crop of IPOs: Bioceres sets terms for $130 million $BIOX $CLXT $IPO #IPO https://t.co/sB2PH7zak2

    Tue Jan 23 20:46:59 - 0 Favorite
  • Diamond Equity Research

    $GEVO could benefit from more sell-side coverage @Gevo_Inc

    Tue Jan 23 20:46:49 - 1 Favorite
  • Diamond Equity Research

    RT @Gevo_Inc: $gevo to Participate in the alphaDIRECT BioEconomy Investor Virtual Conference Series on January 18, 2018. To register for th…

    Tue Jan 23 19:58:35 - 0 Favorite
  • Diamond Equity Research

    $TNXP could benefit from more sell-side coverage @TonixPharma

    Tue Jan 23 19:57:02 - 1 Favorite
  • Diamond Equity Research

    RT @TonixPharma: $TNXP receives notice of allowance for U.S. patent covering use of active ingredient in Tonmya (cyclobenzaprine HCl sublin…

    Tue Jan 23 19:38:23 - 0 Favorite
  • Diamond Equity Research

    $ROKU We just released our latest updates on Roku Inc., please check it out @RokuPlayer https://t.co/weKmNeBOE0

    Tue Jan 23 00:13:36 - 1 Favorite
  • Diamond Equity Research

    RT @ElectraMecc: We're focused on embracing new #technologies and continually innovating to produce the most advanced modes of clean #elect…

    Mon Jan 22 23:21:37 - 0 Favorite
  • Diamond Equity Research

    $IVOB seems to be an interesting investment opportunity @INVOBio_US

    Mon Jan 22 21:03:01 - 0 Favorite
  • Diamond Equity Research

    RT @business: The strategy of adding "blockchain" to a company name is still paying off https://t.co/YYTPE4ZrFD https://t.co/B6b1VBJfCM

    Mon Jan 22 20:13:51 - 0 Favorite
  • Diamond Equity Research

    $CURR could benefit from more sell-side coverage @Cure_Pharma_

    Mon Jan 22 18:52:32 - 0 Favorite

Research Contributor On Widely Followed Investor Platforms